Replies to post #317 on Alexza Pharmaceuticals Inc fka ALXA

[surf1944]

Cypress Bioscience Licenses Alexza Pharmaceutical's Staccato(R) Nicotine
Novel Nicotine Inhaler Technology for Smoking Cessation Will Expand Cypress's CNS Pipeline; Pulmonary Delivery of Pure Nicotine Aerosols May Address Acute Cravings and Help Smokers Quit

http://finance.yahoo.com/news/Cypress-Bioscience-Licenses-iw-811073575.html?x=0&.v=1

[surf1944]

ALXA all the way back from its big gap down & more. News will be coming later this year, but that was an example of what a mishandled order will do do to a small cap biotech stock.